IRVINE, Calif., Oct. 9, 2008 (GLOBE NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host a conference call to review its third quarter 2008 financial results on Tuesday, November 11 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). The call will be open to all investors live via the Investor Relations section of the SenoRx web site at www.senorx.com. A replay of the call will be available on the company's web site approximately 90 minutes after the call concludes. It will also be available to be downloaded as a podcast. Financial results are expected to be released after market close on Monday, November 10.
Details:
What: SenoRx's 2008 Third Quarter Investor Conference Call and Webcast
Date: Tuesday, November 11
Time: 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time
How: Via telephone: Domestic: 877-397-0297;
International: 719-325 4857 Via Internet: www.senorx.com
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor(r) vacuum-assisted breast biopsy system and Contura(tm) MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distributors in more than 20 countries outside the U.S. and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3605